Carregant...
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
"Consilium Medicum" Publishing house
2013-01-01
|
| Col·lecció: | Терапевтический архив |
| Matèries: | |
| Accés en línia: | https://ter-arkhiv.ru/0040-3660/article/view/31226 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|